LEE GUENTHER: Open Payments
NPI 1164852166 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 80 payments from 24 companies in 2025. Trend: 2023 $1,931 · 2024 $1,829 · 2025 $1,570
Food & beverage: $1,398Education: $172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $469 |
| Janssen Biotech, Inc. | 3 | $109 |
| Genentech USA, Inc. | 6 | $108 |
| Eisai Inc. | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 1 | $95 |
| ARGENX US, INC. | 5 | $90 |
| UCB, Inc. | 4 | $81 |
| CATALYST PHARMACEUTICALS, INC. | 3 | $70 |
| Lilly USA, LLC | 3 | $60 |
| TG Therapeutics, Inc. | 3 | $47 |
Products named: UBRELVY, BOTOX, Leqembi, Ocrevus Zunovo, VYALEV, QULIPTA, FYCOMPA, AMYVID.
Industry payments across KY — which companies pay providers there.
